Asset Management One’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Asset Management One’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-63,479	Closed	-$651K	–	1369
2016 Q3	$651K	Hold	63,479	–	–	0.01%	983
2016 Q2	$829K	Hold	63,479	–	–	0.01%	909
2016 Q1	$698K	Hold	63,479	–	–	0.01%	985
2015 Q4	$584K	Hold	63,479	–	–	0.01%	1032
2015 Q3	$441K	Hold	63,479	–	–	0.01%	1085
2015 Q2	$623K	Hold	63,479	–	–	0.01%	1043
2015 Q1	$562K	Hold	63,479	–	–	0.01%	1073
2014 Q4	$556K	Hold	63,479	–	–	0.01%	999
2014 Q3	$437K	Buy	63,479 +41,762	+192%	+$250K	0.01%	1041
2014 Q2	$114K	Hold	21,717	–	–	﹤0.01%	1133
2014 Q1	$99K	Hold	21,717	–	–	﹤0.01%	1106
2013 Q4	$109K	Hold	21,717	–	–	﹤0.01%	1092
2013 Q3	$110K	Buy	+21,717	New	+$121K	﹤0.01%	1088

Other funds holding SCLN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Asset Management One's SCLN Position: Q4 2016 in Review

Asset Management One sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 63,479 shares — an estimated $651K sold.

Asset Management One first reported a position in SCLN in Q3 2013 and held it in 13 quarters. The position peaked at $829K in Q2 2016. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

Asset Management One reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 63,479 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $651K.
Asset Management One first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 13 quarters.
Asset Management One's Sciclone Pharmaceuticals Inc position peaked at $829K in Q2 2016.
153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.